Recent evidence from Wu et al. demonstrated that the rs1260326 variant is associated with altered insulin signaling pathways and elevated triglyceride levels, further linking GCKR polymorphisms to MASLD pathogenesis [44]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.